@article{ajcmr2019711,
author={{Rahman, Eman M. Abdel and EL-Senosy, Fatma M. and Alsebaey, Ayman and Hussien, Shiamaa A.},
title={Neutrophil to Lymphocyte Ratio as Predictive Marker of Recurrence of HCC after Radiofrequency Ablation},
journal={American Journal of Clinical Medicine Research},
volume={7},
number={1},
pages={1--8},
year={2019},
url={http://pubs.sciepub.com/ajcmr/7/1/1},
issn={2328-403X},
abstract={<b>Background:</b> Neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), and prognostic nutritional index (PNI), are immunonutritional indices, have been shown as an independent factor to predict postoperative recurrence and/or overall survival in patients with hepatocellular carcinoma (HCC). <b>Aim:</b> to validate neutrophils-to-lymphocytes ratio (NLR) as a predictor of post radiofrequency ablation recurrence of hepatocellular carcinoma (HCC). <b>Patients and methods:</b> This cross sectional prospective study was conducted on 50 Egyptian patients had radiofrequency ablation for HCC within Barcelona clinical liver cancer (BCLC) stage A. Pre-treatment laboratory tests and imaging were used to measure NLR, PLR, PNI, Child-Pugh (CTP score, tumor number and tumor size. HCC recurrences were followed after three month. <b>Results:</b> According to NLR cut-off value, the patients with NLR >1.73 had larger tumour size, and higher rates of tumor multiplicity .After 3 month follow up 30/50 (60%) patients had tumour recurrence. Regarding recurrence after RFA showed that CTP class B (P&lt;0.05), tumor size (P&lt;0.05), higher rates of tumor multiplicity (P&lt;0.05), decrease PNI (P&lt;0.001) and increased NLR (P&lt;0.05) after RFA and at baseline were found to be worse prognosis. A receiver-operating characteristic (ROC) analysis was used to classify patients as follows: NLR-PNI 0 group (NLR¡Ü1.73 and PNI > 11.74), NLR-PNI 1 group (NLR > 1.73 or PNI ¡Ü 11.74) and NLR-PNI 2 group (NLR > 1.73 and PNI ¡Ü 11.74). The patients with NLR-PNI 2 group had increase in number of portahepatis lymph node, number and size of tumor, decrease serum albumin and change in PNLR. Multivariate analyses suggested increased NLR (hazard ratio [HR] =2.09; 95% confidence interval [CI] =1.88¨C2.55; P&lt;0.05), increased PLR (HR=0.07; 95% CI=0.06¨C0.08; P&lt;0.05), and increased AFP (HR=59.20; 95% CI=-99.74¨C638.78; P&lt;0.05) contributed to post-RFA mortality. <b>Conclusion:</b> High blood NLR after RFA is a predictor for worse survival and also can predict recurrence of HCC. Higher NLR-PNI score predict a worse prognosis in patients who underwent RFA.},
doi={10.12691/ajcmr-7-1-1}
publisher={Science and Education Publishing}
}